Post on 14-Mar-2018
transcript
�� !"#$%&'(
Tzu Chi Med J 2006 � 18 (Suppl 1) �� ! NR
�� !"#$%&'()*
�� �� ��
�� !"#$% �� !"#$%&
�� !"#$%&'()*+,-. P� TMT� �� !"#$%&'()*+,-. �� !"
��
�� !"#$%&'()*+,-.)*+/0123456789:,OMMN�^qmfff�� !"#$%&
�� !"# R�� !"#$%&'emp�molsb=fqJqfjf=OO�� iai�� !"#$ J�� !"#$%&
�� !"iai�� !"NMM=ãÖLÇi�� !"#$%&'!()*+,-./01234iai�QM=ãÖLÇi��
�� !"#$%&'(N��iai�� PM=ãÖLÇi�� !"#$%&'()*+,PMB�� �OMMQ�^qmfff
�� !"#$%&'()*+,-./0123456789:;<=.>?@ABCDEFGH.?I%&J
�� !" iai�� !"#$%&'( ëí~íáå�� ! O�� !"#$%&'()*+,-./012345
�� !"#$%&'()*+,-./01#23456E�� !"#$%NMM=ãÖLÇi��F�� !"#O��
�� !"#$%&'()*+,-./0iai�� TM=ãÖLÇi�� !"#$%&'()*+,-./,01�
�� =2006; 18(Suppl 1):15-19
�� !�� !"#$!%&'
� �
�� !"#$%&'()*+,-./01
�� !"#$%&'"()$%&'"*+&'
�� !"#$%�&'()*+,-.�/01
�� !"#$%&'()*+,-"./'01
�� !"EgçëäáåF�� !"#$%&'E�NF��
NVOO�� !"#$%&'()*+,-./01
�� !"#$NSBJOPB�� !"NVSQ�� !
�UNB�� !"#$ROB�� !"#$NOB�
�� !"#$ OB�� !"# NRB�� !"
�� !"#$%&'RO�� !"#$%&NO�
�� !"#$%&' NR�� !"#$%&' O
�� !"#$%&'()*+,-./012
USB�� !"#$%&'(!)*+,-./0
�� OMMO�NN�� !"�#$%&'()*+
�� !"#$%&'()*+,-./0123
�� !"#$%&'()*+,-.�/012
�� !"#$%&'()*+
�� !"#
�� !"#$%&'(VJNO�� !"#$
�� !"#$%&'()*+,-./012
�� !"�#$%&'E�� ! iaiF�� !
�� !"#E�� ! eaiF�� !"#$%&
�� !"#$%�&'(eai�� iai��
�� !"#$iai�� !"#$%&'()*
�� �� ��
Tzu Chi Med J 2006 � 18 (Suppl 1)NS �� !
�� !"#$%&'()*+,-./0123
�� !"#$%PIMRR�� !"#$%&'()
�� !"EråáíÉÇ= háåÖÇçã= mêçëéÉÅíáîÉ= aá~ÄÉíÉë
píìÇó�� !"rhmapF�� ! PPR�� NM��
�� !"#$%&'()*+,-./0123
�� !"#$%&'iai�eai�^N`�� !
�� xNz�� !"#$%&'()*+,-.
��
�� !"#$%&'()*+
�� !"#$%&'()*+,-.'/
��iai�� eai�� !"#$%&'N��
� O�� !"#$%&'()*+,-.
�� !"#$
�� N�� !"#$%&'()*+,-.
�� !"#$ % �� !"#$%!&'(
�� !"#$%&'()*+%,-.��/0
�� !"#$%&'()*+,-./0123
�� !"#$%&'( O�� !"#$%&'
�� !"#$ �� !"#$%!&'()*
�� !"#$%&'()*+,-./012�
�� !"#$%&'()*+,-./01*!
�� !"#$%&'()*+,"-. ��
�� !"#$%&'()*+,-./012
�� !"#$%&'()*
�� ! O�� !"#$%&'()*+,
�� OMMJQMM=ãÖLÇi�� !"#$ QMM=ãÖLÇi �
�� !"#$%&'()'*+,-./012
�� !"#$%&'()*+,-./01
iai��
�� !"#$%&'()*+,-./01
�� !"#$%& N�� !"#$%&'()
�� !"# O �� !"#$%&'()*+
iai�� !"#$%&'()*+,-./ 0
� iai �� NVM=ãÖLÇi�� !"#$%&'()
�� !"#$%
eai��
eai�� !"#$%&'(#)*+,�-
�� !"#$% �� !"#$eai�� !
�� !"#eai�� !"#$%&'() *
�� !"#$%!eai�� !"#$%&'(
�� !"#$%&'()*+,-./01
�� !"#$%
� NVVU�� e~ÑÑåÉê�� !"b~ëí=~åÇ=tÉëí
�� !"#$%&'()*+,-./0%&,
�� !"#$�%&'()*+,-./!0
�� !xVz�� �OMMN�� !"#$%&'
�� !"#$%&'()E�� !^qmfffF��
�� !"#$xOz�� !"#$%&'()*+
�� !"#$%& iai �� NMM==ãÖLÇi�� !
�� !" R�� !"xPJTz�� !"#$ emp
� molsb=fqJqfjf=OO�� iai�� !"#$ J
�� !"#$%iai�� !"#$%�&'(
�� !"#$%&'iai�QM=ãÖLÇi�� !"
�� !"#$% N��iai�� PM=ãÖLÇi��
�� !"#$%&'()*PMB�� �OMMQ�
^qmfff�� !"#$%&'()*+,-./0
� NK �� gçëäáå�� !"#�� $%&'(#)*+,=E�� F
�� L �� NUVUJNVOO NVOOJNVQV NVRMJNVSQ NVSRJNVTV
�� !" QQKT QKR NKM NKO�� ! OOKS SPKS TTKM TRKS
�� VKV PSKN RPKP RQKR�� PKU RKN VKM TKM� QKV NMKN NOKR NNKN�� QKO NMKN NKP MKV
�� NNKO VKQ RKU QKP�� QKV OKO MKP MKM
�� PKO VKO NMKN NOKM
��
��
��
��
�� !"#$%&'(
Tzu Chi Med J 2006 � 18 (Suppl 1) �� ! NT
�� !"#$%&'()*+=�� !"#$%
�� !"#$%�� !"#$%� !"&'
�� !"#$%&'()*+,-./E�OF=xUz�
�� ^qmfff�� !"#$%&'()*+,-
�� OMB�� !"#$%&'()*+,-.
��ENF�� !"EOF�� !"#$%&'(EPF�
�� !"#$%&'()*+,EQF�� !"#
�� !"#$%&'()*+ ,
^qmfff�� !"#$%&'()*+,-.
�� !"#$%&'!()!*+,!-eai�
�� !"#$%&'()
NK=�� QR�� !"#$RR�� !"#$%&
�� !"#$%&'(
OK=�� !"#$%&'()*+,- RR��
�� SR�� !"#$%&'
PK=�� !"#$�%&
QK=�� !� ≥NQMLVM=ããeÖ�� !"#$%&
�� !
RK=eaiYQM=ãÖLÇi�� eai≥SM=ãÖLÇi�� !"
�� !"#$%&'()*+,-.
�� O�� !"#$%&'()*+,-
�� !"#$%&'($)*+,-./01
�� !"#$%&'()E�� !"#$% NMM
ãÖLÇi��F�� !"# O�� !"#$%&'
�� !"#$%&'( iai�� TM=ãÖLÇi �
�� !"#$%&'()*+,-.+/0
�� !"#
�� !"#$%"#&'()*+,
EíÜÉê~éÉìíáÅ=äáÑÉëíóäÉ=ÅÜ~åÖÉ�� qi`F�� !"#
�� !"#$%&
��OMMQ�^qmfff�� !"#$%&'()
�� !"#$%&'iai��TM=ãÖLÇiE�� !
�� ! iai �� NMM=ãÖLÇiF�� !"#$%&
�� !"#$%&'()*+,-.,/012
�� !"#$%&'()*+,-./01�2
�� !"#$%&'(!" RRB�NRB��
�� !"#$%&'( !�PMB�� !"#
�� !"#E�� !"TB��F�� !"#$
�E�� !" NMB��F�� !"#$%&'(
�� !"E�� !"NMBJNRBF�� !"#$%
�� !OMM�� !"#$%&'(ORM�� !
�� !"#$%&'()*+, -./0 PJQ
�� !"#$%&'()NMJNR�� !"#$%
�� !�"!�#��$%&'(�)*+,�
�� !"#$%&'()*+,-./ L��
�� ! O�� !"#$%&'()*+),
�� !�"#�$%�&'�()�*+�,-
�� !
�� !
^qmfff�� !"#$%&'()*+,-.
�� !"#$%&'(iai��TM=ãÖLÇi��
�� !"#$%&' iai �� NMM=ãÖLÇi��
�� !"#$%&'() iai�� N=ãÖLÇi �
�� !"#$%&'()*+,-. NB�
�� !"ëí~íáå�� !"#$%&'()*
�� !"#$%&'ëí~íáå�� !"#$%%&
�� !"#$%&'()*+,-#./ ^qmfff
�OMMQ�� !"#ëí~íáå�� !"#$%&'(
��iai�� !"#$%&'()*+,- !
� OK �� !"#$%&'()*+,-./0123)4567
� � �� !"#$%&' � � iai�� ! �� !"#$
�� !"#�� GG �� OMB �� !"#$ G YTM=ãÖLÇi iai≥NMM=ãÖLÇi�� OMB �� !" YNMM=ãÖLÇi iai≥NMM=ãÖLÇi
EçéíáçåW=YTM=ãÖLÇiF�� ! ≥O � NMBJOMB �� !"#$ YNPM=ãÖLÇi iai≥NPM=ãÖLÇi
EçéíáçåW=YNMM=ãÖLÇiF�� ! ≥O � �� NMB �� !"# YNPM=ãÖLÇi iai≥NSM=ãÖLÇi�� ! MJN � �� !" YNSM=ãÖLÇi iai≥NVM=ãÖLÇi
G�� !"#$%&'()*+,-./01OMB�� !"#$%&'()*+,!-./012345678ENF�� !"#EOF�� !"#$%&'()EPF�� !"#$%&'()*+,-.EQF�� !"#$%&'GG�� !"#$%&'()*+,-.�� !"#��$%&!"'()
�� �� ��
Tzu Chi Med J 2006 � 18 (Suppl 1)NU �� !
�� !"#$%&'()*+,-PMBJQMB��
�� !"#$%&ëí~íáå�� !"#$%&'(
�� !"#$%&PMBJQMBE�PF�� !"#$
�� !"#$iai�� !"#$%&'()*
�� !"#$ SB=iai �
pí~íáå�� !"#$%&'()*+,ejdJ
`ç^�� �� !"#$%&�'(iai��
�� !siai�iai�� !"#$%iai��
�� !"#$%&'()* eai� pí~íáå��
�� NUBJRRB� iai� TBJPMB�� !"#$
�� RBJNRB�eai�
��ëí~íáå�� !"#$%&'()'*+'
�� !"#$%&'"()"*+,-./01
�� !��"#$ OJP�� !"#$%&'(
� ëí~íáå�� !"#$%&'()*+ ,-.
�� !"#$% ÉêóíÜêçãóÅáå � áíê~Åçå~òçäÉ�
ÅóÅäçëéçêáåÉ�ÖÉãÑáÄêçòáä� ÑÉåçÑáÄê~íÉ�� !"#
�� ÅóíçÅÜêçãÉmP^Q��äçî~ëí~íáå�ëáãî~ëí~íáå�
~íçêî~ëí~íáå � ëí~íáå�� !"#$% ÅóíçÅÜêçãÉ=mJ
QRM�� !"#$%&'()*+, ëí~íáå��
�� !"#$%&'()*+,-./0123
éê~î~ëí~íáå�� !"#$`vm�� !"#$%
�� !"#$xNMJNOz�� !"#eai�� N
ãÖLÇi�� !"#$%&'()OB�� !"#
� ~íçêî~ëí~íáå=�� !eai�� !"#$%&'
�� ~íçêî~ëí~íáå��eai�� !"xNPJNRz��
�� !"#$%& eai�� !"#$%&'
��
�� !ëí~íáå�� !"#$%&'()*+
�� !"#$%&'()*+,-./&012
�� !"#$%&'()*+,-./012�
�� !"#$%&'ëí~íáå��ÑáÄêáÅ=~ÅáÇ�� !
�� !"#$%&'()*+,-./0123
�� !"# ÉòÉíáãáÇÉ�� !"#$%&'()
�� !"#$%&'()*+,-./0��
�� !"#$%�&'()*+,-`vm��
�� !"#$%&'()ëí~íáå=�ÉòÉíáãáÇÉ��
�� !"#$%&'( ~íçêî~ëí~íáå= NM= ãÖ ��
ÉòÉíáãáÇÉNM=ãÖ��iai�� !"# ~íçêî~ëí~íáå=UM
ãÖ=ENM=ãÖ=H=NM=ãÖ=Z=UM=ãÖFxNSz�� !"#$%&
�� !
�� ^qmfff�� !"#$%&'EOMMJRMM
ãÖLÇiF�� !" iai�� !"#$%&'(
åçåJeaiE�� !" eaiF�� !"#$� iai
�� !"PM�� !"#$%&'(#)*+,
�� E≥RMM=ãÖLÇiF�� !"#$%&'()*�
�� !"#$%&'()*+,-./01 2
iai�� !"#$%&' ÑáÄêáÅ=~ÅáÇ�� !"#
��
�� !"#$
�� !"#$OMMP�� !"#$%&'(
�� !"#$OMM=ãÖLÇi��E�� !OMM=ãÖLÇi
��F�iai�� !"#NMM=ãÖLÇi�� eai�
�� !"#$%QM=ãÖLÇi��E�� !PR=ãÖLÇi
��F=�� ! RM=ãÖLÇi��E�� ! QR=ãÖLÇi�
�F�� !"#$%&'()*+ NRM=ãÖLÇi ��
E�� ! NRM=ãÖLÇi ��F=E� QF�
�� !"#$%&'()*+,-./01
�� !"#iai��NMM=ãÖLÇi�� !"#$%
�� !"�#$%iai��NPM=ãÖLÇi�� iai
� NMMJNPM=ãÖLÇi�� !"#$%&'()*+
�� !"#$%&'()*+,-./0
rhmap�� !"#$%&'()*+,- OMMJ
QMM=ãÖLÇi�� !"#$%iai�� !"#$%
� PK �� ëí~íáå�� iai �� PMBJQMB�� !"
� � �� !=E=ãÖLÇiF iai�� ! �� !E=ãÖLÇiFG
içî~ëí~íáå QM PNB UMmê~î~ëí~íáå QM PQB UMpáãî~ëí~íáå OMJQM PRBJQNB UMcäìî~ëí~íáå QMJUM ORBJPRB UM^íçêî~ëí~íáå NM PVB UMoçëìî~ëí~íáå RJNM PVBJQRB QM
G�� !"#$%&'()*+"#%,-./ SBiai
��
�� !"#$%&'(
Tzu Chi Med J 2006 � 18 (Suppl 1) �� ! NV
� QK �� !"#$%&'()*+,-EOMMP �F
�� !"#
�� ! YOMM=ãÖLÇi�� !" YNMM=ãÖLÇi�� !"E�F [ QM=ãÖLÇi�� !"E�F [ RM=ãÖLÇi�� !" YNRM=ãÖLÇi
�� !eai�� !"#$%&'()*+,-
�� !"#$%≥QMM=ãÖLÇi�� !"#$%&
�� !"#$%&'()*+,-./012�
�� !"#$%&'()^qmfff�� !
� �
�� !"#$%&'()*+,-./01
�� !"#$%&'()*+,-.$/012
�� !"N�� LNMM�� !"#$%&OB��
�� !"#$%&'()*+,"-./(01
�NM�� LNMM�� !"#$%&'()*+,-
�NKO�� !"#$%&'()*+,-(./0
�� !"#$%&'()*+,(-./01
�� !"# $%�&'()*+,-./0
�� !"#$%�&'()*+,-#./01
�� !"
�� !
1. Turner RC, Millns H, Neil HA, et al: Risk factors for coro-nary artery disease in non-insulin dependent diabetesmellitus: United Kingdom Prospective Diabetes Study(UKPDS: 23). BMJ 1998; 316:823-828.
2. Expert Panel on Detection, Evaluation, and Treatmentof High Blood Cholesterol in Adults: Executive Summaryof The Third Report of The National Cholesterol Educa-tion Program (NCEP) Expert Panel on Detection,Evaluation, And Treatment of High Blood CholesterolIn Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
3. Jones PH, Davidson MH, Stein EA, et al: Comparisonof the efficacy and safety of rosuvastatin versusatorvastatin, simvastatin, and pravastatin across doses(STELLAR* Trial). Am J Cardiol 2003; 92:152-160.
4. Cannon CP, Braunwald E, McCabe CH, et al: Intensiveversus moderate lipid lowering with statins after acutecoronary syndromes. N Engl J Med 2004; 350:1495-1504.
5. Heart Protection Study Collaborative Group: MRC/BHFHeart Protection Study of cholesterol lowering withsimvastatin in 20,536 high-risk individuals: A randomisedplacebo controlled trial. Lancet 2002; 360:7-22.
6. ALLHAT Officers and Coordinators for the ALLHAT Col-laborative Research Group. The Antihypertensive andLipid-Lowering Treatment to Prevent Heart Attack Trial:Major outcomes in moderately hypercholesterolemic,hypertensive patients randomised to pravastatin vs usualcare: The Antihypertensive and Lipid-Lowering Treat-ment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA2002; 288:2998-3007.
7. Shepherd J, Blauw GJ, Murphy MB, et al: Pravastatinin elderly individuals at risk of vascular disease(PROSPER): A randomised controlled trial. Lancet 2002;360:1623-1630.
8. Grundy SM, Cleeman JI, Merz CN, et al: Implications ofrecent clinical trials for the National Cholesterol Educa-tion Program Adult Treatment Panel III guidelines. Cir-culation 2004; 110:227-239.
9. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, LaaksoM: Mortality from coronary heart disease in subjects withtype 2 diabetes and in nondiabetic subjects with andwithout prior myocardial infarction. N Engl J Med 1998;339:229-234.
10. Lilja JJ, Kivisto KT, Neuvonen PJ: Grapefruit juice in-creases serum concentrations of atorvastatin and hasno effect on pravastatin. Clin Pharmacol Ther 1999; 66:118-127.
11. Neuvonen PJ, Jalava KM: Itraconazole drastically in-creases plasma concentrations of lovastatin andlovastatin acid. Clin Pharmacol Ther 1996; 60:54-61.
12. Kantola T, Kivisto KT, Neuvonen PJ: Erythromycin andverapamil considerably increase serum simvastatin andsimvastatin acid concentrations. Clin Pharmacol Ther1998; 64:177-182.
13. Davidson MH, Ose L, Frohlich J, et al: Differential ef-fects of simvastatin and atorvastatin on high-density lipo-protein cholesterol and apolipoprotein A-I are consis-tent across hypercholesterolemic patient subgroups. ClinCardiol 2003; 26:509-514.
14. Wierzbicki AS, Mikhailidis DP: Dose-response effectsof atorvastatin and simvastatin on high-density lipopro-tein cholesterol in hypercholesterolaemic patients: Areview of five comparative studies. Int J Cardiol 2002;84:53-57.
15. Sever PS, Dahlof B, Poulter NR, et al: Prevention ofcoronary and stroke events with atorvastatin in hyper-tensive patients who have average or lower-than-aver-age cholesterol concentrations, in the Anglo-Scandina-vian Cardiac Outcomes Trial-Lipid Lowering Arm(ASCOT-LLA): A multicentre randomised controlled trial.Lancet 2003; 361:1149-1158.
16. Ballantyne CM, Houri J, Notarbartolo A,et al: Effect ofezetimibe coadministered with atorvastatin in 628 pa-tients with primary hypercholesterolemia: A prospective,randomized, double-blind trial. Circulation 2003; 107:2409-2415.